封面
市場調查報告書
商品編碼
1864337

按劑型、作物類型、應用方法、最終用戶和銷售管道的Buprofezin市場—2025-2032年全球預測

Buprofezin Market by Formulation Type, Crop Type, Application Method, End User, Sales Channel - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,Buprofezin市場規模將成長至 11.6547 億美元,複合年成長率為 5.44%。

關鍵市場統計數據
基準年 2024 7.6259億美元
預計年份:2025年 8.0381億美元
預測年份 2032 11.6547億美元
複合年成長率 (%) 5.44%

對Buprofezin進行了權威的介紹,涵蓋了其作為昆蟲生長調節劑的作用機制、在主要作物中的應用以及監管和管理背景。

在現代綜合蟲害管理(IPM)模式中,Buprofezin作為一種昆蟲生長調節劑,具有獨特的地位。它能抑制主要吸汁害蟲的蛻皮和發育。農民依靠其定向的作用機制來控制威脅棉花、水稻、蔬菜和某些水果作物的粉蝨、介殼蟲、葉蟬和其他半翅目害蟲的數量。由於噻Buprofezin酮作用於幼蟲階段而非直接擊倒,因此在抗藥性緩解和殘留控制等因素影響戰術性策略時,可以有效地與其他化學和生物製劑合併使用。

監管審查和負責任的管理措施正日益影響配方師和施藥人員使用Buprofezin的方式。因此,配方師致力於開發能夠最佳化作物安全性、方便操作人員使用並最大限度減少非目標生物暴露的給藥形式。同時,種植者和顧問也在調整施藥時間和混合策略,以確保產品在害蟲世代更迭中保持有效性。隨著我們從單季病蟲害管理方案轉向全季病蟲害管理方案,相關人員越來越重視作物輪作、監測以及與益蟲族群的共存。

綜合以上趨勢,目前關於Buprofezin的爭論可以概括如下:雖然噻嗪酮是控制特定害蟲群落的有效策略,但其長期效用取決於協調管理、配方創新以及與不斷變化的監管要求保持一致。這些因素正在切實地影響採購決策、宣傳通訊和產品開發藍圖。

變革性的技術、監管和分銷變化將重新定義Buprofezin產品的配方、監管和在作物系統中的部署方式。

Buprofezin的市場格局正在發生變化,多種趨勢正在改變農作物保護產品的研發、行銷和使用方式。精密農業和數位化決策支援工具正在革新施藥時間和劑量選擇,使種植者能夠根據即時病蟲害監測結果,將Buprofezin整合到精準防治策略中。同時,製劑科學也在不斷發展,以提高混配相容性、附著力、耐雨性和作物安全性,進而影響不同種植系統中噻嗪酮類殺蟲劑的應用。

更嚴格的監管以及對環境和工人安全的日益嚴格審查,正在加速對健全的管理方案和透明資料包的需求。因此,生產商和註冊人越來越重視殘留物表徵、非目標風險評估和標籤說明。供應鏈格局也在發生變化,全球採購和原料供應迫使配方商重新評估製造地並重新審視合約夥伴關係。此外,分銷行為的轉變——包括與農民直接互動的增加和線上採購管道的成長——正在改變技術支援和培訓的提供方式。

這些因素相互作用:配方技術的創新和數據驅動的應用技術有助於提高合規性和療效,而不斷演變的經銷和供應模式正在改變資訊和產品到達最終用戶的方式。能夠預見並應對這些變化的相關人員可以提高營運效率,從而保持療效、減少監管摩擦並增強產品的長期生存能力。

受2025年關稅環境影響,供應鏈、採購和分銷環節將發生變化,導致Buprofezin製劑和原料的取得途徑受到影響。

美國2025年實施的關稅和貿易措施對依賴全球供應鏈獲取活性成分、惰性成分和製劑服務的產品(例如Buprofezin)產生了連鎖的間接影響。某些前驅化學品和包裝材料的進口成本上升,推高了國際製劑生產商的單位成本,迫使採購團隊重新評估其供應商組合,並優先考慮在地採購和多元化。為此,一些生產商調整了生產順序和庫存管理策略,以降低關稅波動帶來的風險,並在關鍵種植期保持供應的連續性。

在分銷和終端用戶層面,成本轉嫁動態因通路和客戶類型而異。擁有整合採購結構和長期採購合約的大型農業經營者比依賴現貨採購且營運資金更為緊張的小型農場更能承受短期投入價格波動。此外,關稅引發的變化促使貿易流量重組,一些供應商尋求替代出口目的地,並加快在受關稅影響市場的國內註冊和生產計畫。

重點,政策環境促進了註冊人、合規專業人員和銷售團隊之間的密切合作,以確保貼標產品的持續供應,同時遵守監管義務。總體而言,2025 年關稅趨勢更加強調供應鏈韌性、供應來源多元化以及保護生產商和配方商免受暫時性貿易中斷影響的合約策略。

詳細的細分分析揭示了製劑選擇、作物類別、施用方法、最終用戶畫像和銷售管道如何共同影響Buprofezin的採用決策。

關鍵細分維度的洞察揭示了Buprofezin產品的差異化需求促進因素、施用方法偏好和商業化策略。根據製劑類型,相關人員會評估濃縮液、顆粒劑、濃縮液和可濕性粉劑在特定施用時間、作物安全性以及操作人員操作要求方面的適用性。在需要快速混合和界面活性劑相容性的場合,濃縮液往往是首選;而顆粒劑則可透過土壤或水進行靶向施用,適用於水稻和撒播。在藥效依賴葉面接觸和在複雜冠層中均勻覆蓋的情況下,懸浮劑和可濕性粉劑仍然具有價值。

目錄

第1章:序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 溫室蔬菜中越來越多採用Buprofezin製劑防治粉蝨
  • 在永續作物保護計畫中擴大經有機認證的Buprofezin酮類生物防治劑的使用規模
  • 將無人機精準噴灑技術應用於大規模棉花種植中的Buprofezin防治
  • 亞太市場對Buprofezin在水稻種植的應用監管核准不斷增加
  • 開發奈米封裝的Buprofezin淨遞送系統以提高其在野外的穩定性和療效
  • 農藥生產商之間關於Buprofezin專利聯盟和共同開發的策略聯盟
  • 原物料成本上漲對主要生產商Buprofezin生產利潤率的影響
  • 綜合蟲害管理 (IPM) 的日益普及推動了 IPM 計畫中Buprofezin的使用量增加。

第6章:美國關稅的累積影響,2025年

第7章:人工智慧的累積影響,2025年

第8章 以劑型分類的Buprofezin市場

  • 乳化濃縮液
  • 顆粒
  • 暫停
  • 可濕性粉

第9章 依作物類型分類的Buprofezin市場

  • 棉布
  • 果樹
    • 莓果
    • 柑橘
    • 核果
  • 蔬菜
    • 水果和蔬菜
    • 綠葉蔬菜
    • 根莖類

第10章 依應用方法分類的Buprofezin市場

  • 葉面噴布
  • 種子處理
  • 土壤處理

第11章Buprofezin市場:依最終用戶分類

  • 大型農場
  • 小農場

第12章Buprofezin市場銷售管道

  • 直銷
  • 批發商
  • 線上

第13章Buprofezin市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章Buprofezin市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國Buprofezin市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣,2024
  • 競爭分析
    • Sumitomo Chemical Co., Ltd.
    • Nippon Soda Co., Ltd.
    • Jiangsu Changqing Agrochemical Co., Ltd.
    • Adama Agricultural Solutions Ltd.
    • UPL Limited
    • Dhanuka Agritech Limited
    • Nufarm Limited
    • Jiangsu Huifeng Agrochemical Co., Ltd.
    • Shandong United Pesticide Industry Co., Ltd.
    • Gharda Chemicals Limited
Product Code: MRR-2B4B2861EC8B

The Buprofezin Market is projected to grow by USD 1,165.47 million at a CAGR of 5.44% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 762.59 million
Estimated Year [2025] USD 803.81 million
Forecast Year [2032] USD 1,165.47 million
CAGR (%) 5.44%

An authoritative introduction to buprofezin covering its insect growth regulator mode of action, primary crop applications, regulatory and stewardship context

Buprofezin occupies a distinct position within contemporary integrated pest management frameworks as an insect growth regulator that disrupts molting and development in key sap-sucking pests. Agricultural practitioners rely on its targeted mode of action to manage populations of whiteflies, scale insects, planthoppers, and other hemipteran pests that threaten cotton, rice, vegetables, and certain fruit categories. Because it affects immature stages rather than providing acute knockdown, buprofezin integrates effectively with complementary chemistries and biological agents when resistance mitigation and residue considerations shape tactical decisions.

Regulatory scrutiny and stewardship commitments increasingly influence the way formulators and applicators deploy buprofezin. Consequently, formulators have invested in delivery formats that optimize crop safety and operator handling while minimizing non-target exposure. In parallel, growers and advisors have adapted application timing and tank-mix strategies to preserve product efficacy across successive pest generations. Transitioning from single-season interventions toward season-long pest management programs, stakeholders emphasize rotation, monitoring, and compatibility with beneficial insect populations.

Taken together, these dynamics frame the current discourse around buprofezin: it is a strategic tool for controlling specific pest complexes, yet its long-term utility depends on coordinated stewardship, formulation innovation, and alignment with evolving regulatory expectations. Those factors shape procurement decisions, extension messaging, and product development roadmaps in practical ways.

Transformative technological, regulatory, and distributional shifts that are redefining how buprofezin products are formulated, regulated, and deployed across crop systems

The landscape for buprofezin is shifting as several transformative trends converge to reshape how crop protection products are developed, marketed, and used. Precision agriculture and digital decision-support tools have changed application timing and dosage selection, enabling growers to integrate buprofezin into targeted interventions informed by real-time pest monitoring. At the same time, formulation science has evolved to address compatibility with tank-mix partners and to improve adherence, rainfastness, and crop safety, which in turn influences product uptake across diverse cropping systems.

Regulatory tightening and heightened scrutiny on environmental and operator safety have accelerated demand for robust stewardship programs and transparent data packages. Consequently, manufacturers and registrants place greater emphasis on residue characterization, non-target risk assessments, and label clarity. Supply chain dynamics have also changed, as global sourcing and raw material availability prompt formulators to re-evaluate manufacturing footprints and contract partnerships. In addition, shifts in distribution behavior - including expanding direct-to-grower engagement and the growth of online procurement channels - are altering how technical support and training are delivered.

These forces operate together: innovation in formulation and data-driven application practices supports compliance and efficacy, while evolving distribution and supply arrangements change how information and product reach end users. Stakeholders who anticipate and respond to these shifts can protect efficacy, reduce regulatory friction, and capture operational efficiencies that strengthen long-term product viability.

How the 2025 tariff environment produced cascading supply chain, procurement, and distribution effects that reshaped access to buprofezin formulations and inputs

The implementation of tariffs and trade measures by the United States in 2025 created a cascade of indirect effects for products like buprofezin that rely on global supply chains for active ingredients, inert components, and formulation services. Increased import costs for certain precursor chemicals and packaging materials raised the unit cost base for formulators who sourced components internationally, prompting procurement teams to reevaluate supplier portfolios and to prioritize localized or diversified supply relationships. In turn, some manufacturers adjusted production sequencing and inventory policies to mitigate exposure to tariff volatility and to preserve continuity of supply for key cropping periods.

At the distribution and end-user level, cost pass-through dynamics varied by channel and customer type. Large agricultural operations with integrated purchasing and longer-term procurement contracts absorbed short-term input price movements more easily than small-scale farms that depend on spot purchases and may face tighter working capital constraints. Moreover, tariff-driven changes fostered reconfiguration in trade flows, encouraging some suppliers to seek alternative export destinations or to accelerate domestic registration and production plans in tariff-affected markets.

Importantly, the policy environment stimulated closer collaboration between registrants, compliance specialists, and commercial teams to ensure uninterrupted access to labeled products while remaining compliant with regulatory obligations. In sum, tariff developments in 2025 heightened focus on supply chain resilience, supplier diversification, and contractual strategies that buffer growers and formulators from episodic trade disruptions.

Granular segmentation insights revealing how formulation choices, crop categories, application methods, end-user profiles, and sales channels collectively shape buprofezin deployment decisions

Insights across key segmentation dimensions reveal differentiated demand drivers, application preferences, and commercialization strategies for buprofezin products. Based on formulation type, stakeholders evaluate emulsifiable concentrates, granules, suspension concentrates, and wettable powders for their fit with specific application windows, crop safety profiles, and operator handling requirements; emulsifiable concentrates often appeal where rapid mixing and compatibility with surfactants matter, while granule formats can offer targeted soil- or water-delivered options for paddy or broadcast applications. Suspension concentrates and wettable powders remain valuable where foliar contact and uniform coverage across complex canopies determine efficacy.

Based on crop type, users tailor selection to the pest complex and crop physiology. Cotton, fruit, paddy, and vegetables each present unique considerations: cotton programs prioritize control of sap-sucking pests across multiple growth stages; fruit applications require attention to preharvest intervals and pollinator exposure, with fruit categories further dissected across berry, citrus, and stone fruit for varying residue and canopy management needs; paddy systems often favor formulations and application windows synchronized with planthopper life cycles; vegetables require agile application timing across fruit vegetables, leafy vegetables, and root vegetables where harvest schedules and residue tolerances differ.

Based on application method, deployment choices cluster around foliar spray, seed treatment, and soil treatment options, with foliar spray remaining the prevalent mode for rapid suppression of active infestations and seed or soil treatments offering prophylactic protection in select systems. Based on end user, the distinction between large scale farms and small scale farms affects purchasing patterns, technical support needs, and willingness to adopt premium formulations or subscription-based supply models. Based on sales channel, direct sales, distributors, and online platforms each present trade-offs between hands-on technical service, reach into fragmented geographies, and convenience; distributors often provide localized agronomic support while direct sales can bundle technical training and stewardship commitments, and online channels increasingly serve smaller buyers seeking transactional convenience. Together, these segmentation lenses inform product development priorities, extension strategies, and channel investments in ways that reflect agronomic realities and commercial constraints.

Regional agronomic, regulatory, and distribution nuances across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine product use and commercialization pathways

Regional dynamics shape how buprofezin is used, regulated, and commercialized across diverse cropping systems. In the Americas, adoption patterns reflect a mix of specialty crop and row crop needs; technical support and distributor networks play a central role in translating label constraints into field practice, and growers often seek integration with broader pest management tools suitable for cotton, vegetables, and fruit systems. Regulatory engagement and stewardship programs in this region emphasize worker safety and environmental risk mitigation, which influence formulation preferences and application timing.

In Europe, Middle East & Africa, regulatory frameworks and regional climatic diversity create heterogeneous demand and approval conditions. Some jurisdictions emphasize stringent residue and non-target species assessments that shape label language and permissible use patterns, while others prioritize access for key staple or export-oriented crops. Technical advisories and extension networks in these geographies frequently guide growers toward integrated approaches that balance efficacy with compliance and market access objectives.

In Asia-Pacific, agricultural systems characterized by intensive rice cultivation, extensive vegetable production, and significant smallholder presence rely heavily on targeted tools for planthopper and sap-sucking pest complexes. Here, formulations that suit paddy application regimes and mixed-cropping calendars gain traction, and stewardship messaging that accounts for multiple cropping cycles proves essential. Across regions, supply chain configuration, regulatory drivers, and agronomic practices interact to determine which channels, formulations, and advisory models best support effective and sustainable use.

Strategic company-level imperatives focusing on formulation innovation, regulatory stewardship, channel partnerships, and service integration to sustain competitive advantage

Competitive dynamics among manufacturers, formulators, and service providers center on formulation innovation, regulatory expertise, and channel reach. Leading enterprises prioritize investments in formulation platforms that enhance compatibility with precision application technologies and that reduce operator exposure while maintaining efficacy against target pest complexes. At the same time, contract manufacturing and private-label arrangements allow regional formulators to tailor products to local cropping systems and regulatory conditions, creating opportunities for agile market entrants.

R&D teams and regulatory affairs specialists collaborate to build robust data packages that support label renewal, risk mitigation, and stewardship initiatives. Partnerships between technical teams and commercial units increasingly aim to translate efficacy data into actionable extension materials and training programs for distributors and end users. Additionally, companies that offer integrated services - combining product supply with digital advisory tools, monitoring services, or custom formulations - differentiate on the basis of convenience and technical value.

Mergers, licensing arrangements, and distribution partnerships remain important mechanisms for scaling geographic reach and accelerating product registration timelines without duplicative capital investment. In this environment, firms that maintain strong relationships with growers, extension agents, and channel partners can more effectively deploy stewardship programs and respond to evolving regulatory expectations, thereby preserving product relevance over multiple cropping cycles.

Actionable recommendations for manufacturers and distributors to fortify supply resilience, advance stewardship, and optimize commercialization of buprofezin products

Industry leaders can take several practical steps to strengthen product resilience, protect efficacy, and expand responsible use of buprofezin. First, prioritize formulation development that improves ease of use, reduces operator exposure, and enhances compatibility with integrated pest management practices; investing in adjuvant science and delivery systems reduces barriers to adoption and can lengthen product lifecycle utility. Second, build robust stewardship and resistance management programs that combine clear label instructions, train-the-trainer initiatives for distributors and advisors, and monitoring protocols that inform rotation and tank-mix choices.

Third, diversify supply chains by securing multiple qualified suppliers for key inputs and by assessing local or regional manufacturing options to reduce exposure to trade volatility. Fourth, strengthen relationships with end users through bundled services that include agronomic advisory, digital decision-support tools, and field-level diagnostics; these offerings create recurring engagement and improve proper product use. Fifth, engage proactively with regulatory authorities and industry associations to streamline data submissions, address non-target risk considerations, and align residue management strategies with export market requirements.

Finally, tailor commercialization strategies to channel dynamics: support distributors with localized technical materials, develop direct-sales pilots for high-value customers, and design online offerings for smaller buyers who value convenience. By combining technical innovation with supply resilience and targeted commercial models, industry leaders can sustain product relevance while meeting evolving regulatory and grower expectations.

A transparent hybrid research methodology combining primary interviews, regulatory and technical literature review, and field validation to triangulate practical insights on buprofezin use

This research synthesizes insights from a hybrid methodology combining primary interviews, regulatory documentation review, technical literature synthesis, and field-level observation to ensure robust, triangulated findings. Primary qualitative interviews included crop protection specialists, formulation scientists, registrants' regulatory leads, distributors, and grower advisors to capture on-the-ground practices and strategic priorities. Complementary secondary analysis drew on peer-reviewed entomology and agronomy literature, publicly available regulatory filings, and company disclosures to contextualize efficacy profiles, residue management practices, and label constraints.

Field-level observation and practitioner feedback informed assessments of application timing, formulation performance under diverse climatic conditions, and stewardship practices at farm scale. Data triangulation helped reconcile differences between controlled-trial efficacy and practical in-field outcomes, while expert validation workshops reviewed preliminary conclusions to ensure relevance and clarity. Quality assurance measures included cross-referencing regulatory documents against reported use patterns and seeking clarifications from technical interviewees when discrepancies emerged.

Throughout the research process, ethical considerations and confidentiality requirements guided interactions with commercial participants. The methodology emphasizes transparency in source attribution and replicability of approach while acknowledging practical limitations inherent in rapidly evolving regulatory and trade contexts.

Concluding synthesis emphasizing the sustained agronomic role of buprofezin alongside the necessity for stewardship, supply resilience, and coordinated commercial strategies

In conclusion, buprofezin remains a targeted and valuable tool within integrated pest management programs for specific sap-sucking pest complexes across cotton, rice, vegetables, and select fruit crops. Its role is reinforced by formulation advancements and data-driven application practices, even as regulatory scrutiny and trade dynamics challenge supply continuity and cost structures. The combined pressures of stewardship expectations, changing distribution channels, and trade policy shifts necessitate adaptive approaches in procurement, product development, and grower engagement.

Stakeholders that align formulation innovation with robust stewardship, diversify supply relationships, and invest in channel-specific technical support will better sustain efficacy and retain grower confidence. Moreover, integrating digital advisory services and localized training into commercialization strategies strengthens correct use and reduces the risk of resistance development. As the sector evolves, decision-makers should prioritize operational resilience and proactive regulatory engagement to preserve both access and product integrity.

Taken together, these conclusions underscore the importance of coordinated action across R&D, regulatory, supply chain, and commercial functions to maintain the utility of buprofezin in modern crop protection portfolios while addressing environmental and market expectations.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of buprofezin formulations for controlling whitefly infestations in greenhouse vegetables
  • 5.2. Expansion of organic-certified buprofezin-based bioinsecticides in sustainable crop protection programs
  • 5.3. Integration of drone-based precision application techniques for buprofezin in large-scale cotton farming
  • 5.4. Increasing regulatory approvals of buprofezin for use in paddy rice cultivation across Asia Pacific markets
  • 5.5. Development of nano-encapsulated buprofezin delivery systems to enhance field stability and efficacy
  • 5.6. Strategic collaborations between agrochemical companies for buprofezin patent pooling and co-development
  • 5.7. Impact of rising raw material costs on buprofezin production margins among key manufacturers
  • 5.8. Surge in integrated pest management adoption driving increased use of buprofezin in IPM programs

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Buprofezin Market, by Formulation Type

  • 8.1. Emulsifiable Concentrate
  • 8.2. Granule
  • 8.3. Suspension Concentrate
  • 8.4. Wettable Powder

9. Buprofezin Market, by Crop Type

  • 9.1. Cotton
  • 9.2. Fruit
    • 9.2.1. Berry
    • 9.2.2. Citrus
    • 9.2.3. Stone Fruit
  • 9.3. Paddy
  • 9.4. Vegetables
    • 9.4.1. Fruit Vegetables
    • 9.4.2. Leafy Vegetables
    • 9.4.3. Root Vegetables

10. Buprofezin Market, by Application Method

  • 10.1. Foliar Spray
  • 10.2. Seed Treatment
  • 10.3. Soil Treatment

11. Buprofezin Market, by End User

  • 11.1. Large Scale Farms
  • 11.2. Small Scale Farms

12. Buprofezin Market, by Sales Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online

13. Buprofezin Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Buprofezin Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Buprofezin Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Sumitomo Chemical Co., Ltd.
    • 16.3.2. Nippon Soda Co., Ltd.
    • 16.3.3. Jiangsu Changqing Agrochemical Co., Ltd.
    • 16.3.4. Adama Agricultural Solutions Ltd.
    • 16.3.5. UPL Limited
    • 16.3.6. Dhanuka Agritech Limited
    • 16.3.7. Nufarm Limited
    • 16.3.8. Jiangsu Huifeng Agrochemical Co., Ltd.
    • 16.3.9. Shandong United Pesticide Industry Co., Ltd.
    • 16.3.10. Gharda Chemicals Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BUPROFEZIN MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BUPROFEZIN MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BUPROFEZIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BUPROFEZIN MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BUPROFEZIN MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BUPROFEZIN MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BUPROFEZIN MARKET SIZE, BY GRANULE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BUPROFEZIN MARKET SIZE, BY SUSPENSION CONCENTRATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BUPROFEZIN MARKET SIZE, BY WETTABLE POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BUPROFEZIN MARKET SIZE, BY COTTON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BUPROFEZIN MARKET SIZE, BY BERRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BUPROFEZIN MARKET SIZE, BY CITRUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BUPROFEZIN MARKET SIZE, BY STONE FRUIT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BUPROFEZIN MARKET SIZE, BY PADDY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BUPROFEZIN MARKET SIZE, BY VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BUPROFEZIN MARKET SIZE, BY FRUIT VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BUPROFEZIN MARKET SIZE, BY LEAFY VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BUPROFEZIN MARKET SIZE, BY ROOT VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BUPROFEZIN MARKET SIZE, BY FOLIAR SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BUPROFEZIN MARKET SIZE, BY SEED TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BUPROFEZIN MARKET SIZE, BY SOIL TREATMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BUPROFEZIN MARKET SIZE, BY LARGE SCALE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BUPROFEZIN MARKET SIZE, BY SMALL SCALE FARMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BUPROFEZIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BUPROFEZIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BUPROFEZIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BUPROFEZIN MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BUPROFEZIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BUPROFEZIN MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 293. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. ASEAN BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 299. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GCC BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. GCC BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. GCC BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 306. GCC BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 307. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 308. GCC BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 309. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 310. GCC BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 311. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. GCC BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. GCC BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. BRICS BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 336. BRICS BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 337. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 338. BRICS BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 339. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 340. BRICS BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 341. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 342. BRICS BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 343. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. BRICS BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 346. BRICS BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 347. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 348. G7 BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 349. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. G7 BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. G7 BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 354. G7 BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 355. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 356. G7 BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 357. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 358. G7 BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)
  • TABLE 359. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 360. G7 BUPROFEZIN MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 361. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 362. G7 BUPROFEZIN MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 363. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 364. NATO BUPROFEZIN MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 365. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 366. NATO BUPROFEZIN MARKET SIZE, BY FORMULATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 367. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 368. NATO BUPROFEZIN MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 369. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2018-2024 (USD MILLION)
  • TABLE 370. NATO BUPROFEZIN MARKET SIZE, BY FRUIT, 2025-2032 (USD MILLION)
  • TABLE 371. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2018-2024 (USD MILLION)
  • TABLE 372. NATO BUPROFEZIN MARKET SIZE, BY VEGETABLES, 2025-2032 (USD MILLION)
  • TABLE 373. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2018-2024 (USD MILLION)
  • TABLE 374. NATO BUPROFEZIN MARKET SIZE, BY APPLICATION METHOD, 2025-2032 (USD MILLION)

TABLE 375